Acticor Biotech updates its glenzocimab clinical development plan for the treatment of cardiovascular emergencies
GlobeNewswire
*Acticor Biotech updates its glenzocimab clinical development plan for the treatment of cardiovascular..
*Acticor Biotech updates its glenzocimab clinical development plan for the treatment of cardiovascular..
The Parliamentary Health Service Ombudsman (PHSO) said it had “real concerns” over reviews of patient safety, culture and..
A survey of over 7,000 staff at University Hospitals Birmingham NHS Foundation Trust took part in the survey